
Events | AbbVie
Jul 31, 2025 · In addition to the Offer to Exchange, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, AbbVie files annual, …
AbbVie (ABBV) Stock Price & Overview
4 days ago · A detailed overview of AbbVie Inc. (ABBV) stock, including real-time price, chart, key statistics, news, and more.
AbbVie Inc.: Company Events Publications and Financial Calendar | ABBV …
AbbVie Inc. company earnings calendar and analyst expectations - Upcoming and past events | Nyse: ABBV | Nyse
AbbVie Stock Price History - Investing.com
Dec 9, 2025 · Access AbbVie stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.
Financial releases | AbbVie
Jun 30, 2025 · NORTH CHICAGO, Ill. , Jan. 7, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2025 financial results on Wednesday, February 4, 2026 , …
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings …
5 days ago · AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call NORTH CHICAGO, Ill., Jan. 7, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and …
AbbVie Inc. (ABBV) Stock Historical Prices & Data - Yahoo Finance
Discover historical prices for ABBV stock on Yahoo Finance. View daily, weekly or monthly format back to when AbbVie Inc. stock was issued.
AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jan 10, 2025 · AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Management will participate in a fireside chat at …
AbbVie (ABBV) Stock Price History 2012-2026
Dec 10, 2012 · A complete stock price history for AbbVie Inc. (ABBV) stock, starting from its first trading day. Includes open, high, low, close and volume.
AbbVie (ABBV) Stock: What to Know Before the US Market Opens on ...
Dec 14, 2025 · AbbVie Inc. (NYSE: ABBV) heads into the Monday, December 15, 2025 US market open with a familiar “big pharma” setup—steady cash returns, blockbuster execution, and a pipeline that’s …